Primary Imiquimod Treatment versus Surgery for Vulvar Intraepithelial Neoplasia: A Prospective Randomized Controlled Trial [Primäre Therapie mit Imiquimod versus Chirurgie zur Behandlung der Vulvären intraepithelialen Neoplasie]

Trial Profile

Primary Imiquimod Treatment versus Surgery for Vulvar Intraepithelial Neoplasia: A Prospective Randomized Controlled Trial [Primäre Therapie mit Imiquimod versus Chirurgie zur Behandlung der Vulvären intraepithelialen Neoplasie]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Vulvar intraepithelial neoplasia; Vulvovaginal cancer
  • Focus Therapeutic Use
  • Acronyms PITVIN
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2018.
    • 16 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top